Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06052202 · ClinicalTrials.gov registry record · NA
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
A NA study, sponsored by ISA Associates.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT06052202 is a NA study that has completed, run by ISA Associates. The registered enrollment target is 128 participants.
The verdict
NCT06052202, a NA study, has completed, sponsored by ISA Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test a new smartphone-based program designed to help African American men get screened for colorectal cancer (CRC). The main question it aims to answer is: ° Are African American men who complete the smartphone-based program more likely to get screened for colorectal cancer than men who do not? Participants will: * Complete a baseline survey asking about their colorectal cancer screening history and their thoughts and beliefs about colorectal cancer and the medical system. * Be randomized to receive the new smartphone-based program or to receive text messages containing colorectal cancer education materials designed by the Centers for Disease Control (CDC). The new program sends text messages with information about colorectal cancer. Some of these text messages have links to videos that try to help men overcome anything that may stand in the way of getting screened. * Complete a follow-up survey 6 months after the baseline survey. This survey will ask the same questions as the baseline survey. * A medical records review will be conducted at 6 months to verify whether participants received a colorectal cancer screening test during the study period. Researchers will compare participants who receive the new smartphone-based program to participants who receive the CDC information. The goal is to see whether the smartphone-based program increasing screening more than standard educational materials available on the internet.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL CRC mHealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2023-12-08 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06052202
The ClinicalTrials.gov registry entry for NCT06052202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ISA Associates, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT06052202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06052202 about?
NCT06052202 is a clinical study titled "A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men". The goal of this clinical trial is to test a new smartphone-based program designed to help African American men get screened for colorectal cancer (CRC). The main question it aims to answer is: ° Are African American men who complete the smartphone-based program more likely to get screened for colo...
What is the current status of trial NCT06052202?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2023-12-08. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT06052202?
The interventions under investigation include: Control (BEHAVIORAL), CRC mHealth (BEHAVIORAL).
Who is sponsoring clinical trial NCT06052202?
This trial is sponsored by ISA Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.